Novavax annual gross profit
2020
2021
2022
2023
2024
2025
Novavax Gross Profit Growth & History (NVAX)
Novavax's gross profit was $1.05B for fiscal 2025.
View full Novavax company overviewNovavax annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.05B | $571.0M | +119.10% |
| 2024 | 2024-12-31 | $479.4M | −$160.5M | −25.08% |
| 2023 | 2023-12-31 | $639.9M | −$439.3M | −40.70% |
| 2022 | 2022-12-31 | $1.08B | −$67.1M | −5.85% |
| 2021 | 2021-12-31 | $1.15B | $670.7M | +141.02% |
| 2020 | 2020-12-31 | $475.6M | — | — |
Novavax quarterly gross profit
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $42.5M | −$181.5M | −81.04% |
| Q1 2026 | 2026-03-31 | $108.8M | −$543.7M | −83.32% |
| Q4 2025 | 2025-12-31 | $125.0M | $73.4M | +142.12% |
| Q3 2025 | 2025-09-30 | $48.9M | $25.1M | +104.87% |
| Q2 2025 | 2025-06-30 | $223.9M | −$145.3M | −39.36% |
| Q1 2025 | 2025-03-31 | $652.5M | $617.9M | +1783.45% |
| Q4 2024 | 2024-12-31 | $51.6M | −$84.7M | −62.13% |
| Q3 2024 | 2024-09-30 | $23.9M | −$64.2M | −72.87% |
| Q2 2024 | 2024-06-30 | $369.2M | $593,000 | +0.16% |
| Q1 2024 | 2024-03-31 | $34.6M | −$12.2M | −26.07% |
| Q4 2023 | 2023-12-31 | $136.4M | −$39.3M | −22.36% |
| Q3 2023 | 2023-09-30 | $88.1M | −$211.9M | −70.65% |
| Q2 2023 | 2023-06-30 | $368.6M | $453.8M | — |
| Q1 2023 | 2023-03-31 | $46.9M | −$641.9M | −93.20% |
| Q4 2022 | 2022-12-31 | $175.6M | −$46.6M | −20.96% |
| Q3 2022 | 2022-09-30 | $300.0M | $121.1M | +67.74% |
| Q2 2022 | 2022-06-30 | −$85.2M | −$383.2M | — |
| Q1 2022 | 2022-03-31 | $688.8M | $241.5M | +54.01% |
| Q4 2021 | 2021-12-31 | $222.2M | — | — |
| Q3 2021 | 2021-09-30 | $178.8M | — | — |
| Q2 2021 | 2021-06-30 | $298.0M | — | — |
| Q1 2021 | 2021-03-31 | $447.2M | — | — |
Novavax gross profit trends
Over the last five fiscal years, Novavax's gross profit increased from $475.6M to $1.05B, a change of $574.8M. The latest reported quarter, Q2 2026, shows $42.5M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Novavax source filings ↗